|
Home | Medical-Newswire.Com:
|
(Medical-NewsWire.com, October 13, 2015 ) The cancer diagnostics market is on the verge of explosion, as the researchers approach major technological breakthroughs in tumor diagnosis and therapy, discover new specific antigens, and unlock the mystery of the genetic basis of the disease. During the next ten years, the worldwide cancer testing market is promising to be an exciting, dynamic and rapidly expanding field. Anticipated technological breakthroughs will create numerous opportunities for determining genetic predisposition, detecting specific tumors, and monitoring biological response to cancer therapy. The rise in geriatric population will further compound the growing demand for malignancy assays and the rapid market expansion worldwide.
This report presents a detailed analysis of the Occult Blood testing market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan, including clinical significance and current laboratory practice; 5- and 10-year test volume and sales forecasts by country and market segment; as well as sales and market shares for major suppliers.
Enquire about this report @ http://www.bigmarketresearch.com/report-enquiry/330934
The report also examines market applications of DNA probes, biochips/microarrays, monoclonal antibodies, immunoassays, IT, chromosome analysis, and other technologies; reviews features and operating characteristics of automated analyzers; profiles leading suppliers and recent market entrants developing innovative technologies and products; and identifies alternative market penetration strategies and entry barriers/risks.
Table of Contents:
1. INTRODUCTION
2. OCCULT BLOOD WORLDWIDE MARKET AND TECHNOLOGY OVERVIEW
A. Occult Blood: Clinical Significance and Laboratory Practices
B. INSTRUMENTATION REVIEW And Market Needs
C. CURRENT AND EMERGING TECHNOLOGIES
1. MONOCLONAL AND POLYCLONAL ANTIBODIES
2. IMMUNOASSAYS
3. MOLECULAR DIAGNOSTICS
4. CHROMOSOME ANALYSIS
5. ARTIFICIAL INTELLIGENCE
6. FLOW CYTOMETRY
7. TWO DIMENSIONAL GEL ELECTROPHORESIS (2DGE)
8. BIOSENSORS
9. COMPETING/COMPLEMENTING TECHNOLOGIES
E. Personal Testing
3. FRANCE: TEST VOLUME AND DIAGNOSTICS SALES FORECAST BY MARKET SEGMENT
4. GERMANY: TEST VOLUME AND DIAGNOSTICS SALES FORECAST BY MARKET SEGMENT
5. ITALY: TEST VOLUME AND DIAGNOSTICS SALES FORECAST BY MARKET SEGMENT
6. JAPAN: TEST VOLUME AND DIAGNOSTICS SALES FORECAST BY MARKET SEGMENT
7. SPAIN: TEST VOLUME AND DIAGNOSTICS SALES FORECAST BY MARKET SEGMENT
8. U.K.: TEST VOLUME AND DIAGNOSTICS SALES FORECAST BY MARKET SEGMENT
9. U.S.A.: TEST VOLUME AND DIAGNOSTICS SALES FORECAST BY MARKET SEGMENT
10. DESIGN CRITERIA FOR DECENTRALIZED TESTING PRODUCTS
11. ALTERNATIVE MARKET PENETRATION STRATEGIES
A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies
1. MARKETING APPROACHES
2. PRODUCT COMPLEXITY
3. CUSTOMER PREFERENCE
4. ESTABLISHED SUPPLIERS
5. EMERGING SUPPLIERS
6. MAJOR TYPES OF DISTRIBUTORS
7. MARKET SEGMENTATION FACTOR
12. POTENTIAL MARKET ENTRY BARRIERS AND RISKS
A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges
13. COMPETITIVE PROFILES
Abbott
AdnaGen
Applied Gene Technologies
Arca Biopharma
Beckman Coulter/Danaher
Becton Dickinson
Biomedical Diagnostics
bioMerieux
BioRad
Cepheid
Correlogic Systems
Decode Genetics
Diadexus
Diagnocure
Diasorin
Eiken Chemical
Elitech Group
Enterix
Enzo Biochem
Epigenomics
Exact Sciences
Fujirebio
Hologic/GenProbe
Guided Therapeutics
Kreatech
Kyowa Medex
Mackay Life Sciences
Myriad Genetics
OncoLab
OrthoClinical Diagnostics
Panacea Pharmaceuticals
Polartechnics
Polymedco
Big Market Research
James Jordan
+ 1-503-894-6022
james@bigmarketresearch.com
Source: EmailWire.Com 
Source: EmailWire.com
|
|
|
|
